@article {10459, title = {HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection.}, journal = {HLA}, volume = {89}, year = {2017}, month = {2017 03}, pages = {135-142}, abstract = {

BACKGROUND: Hepatitis C virus (HCV) is able to bypass the immune system modulating innate and adaptive immune response and blocking T helper 1 (Th1) cell production. Because the human leukocyte antigen (HLA)-G molecule has immunomodulatory properties inhibiting the function and production of natural killer and cytotoxic lymphocyte T cells, as well as promoting shift from Th1 toward Th2 response, we hypothesized its involvement in susceptibility to HCV infection.

MATERIALS AND METHODS: Considering that HLA-G mRNA expression has been reported to be under genetic control, an association study was conducted analyzing 800 base pairs upstream the ATG at the 5{\textquoteright}upstream regulator region (URR) and 850 base pairs from ATG to exon 3 and the 3{\textquoteright}untranslated region (UTR) of HLA-G gene in Italian HCV-positive patients and uninfected controls.

RESULTS: Four 5{\textquoteright}URR polymorphisms (-725C>G>T, -509C>G, -400G>A and -398G>A), 7 polymorphisms at coding region (+15G>A, +36G>A, +243G>A, insC506, 531G>C, delA615 and 685G>A), the +644G>T polymorphism, and 1 haplotype (TTGTTCCIGAC) showed different frequency distributions between HCV patients and uninfected controls.

CONCLUSION: The results from our study suggest a possible involvement of HLA-G in the risk modulation toward HCV infection.

}, keywords = {3{\textquoteright} Untranslated Regions, 5{\textquoteright} Untranslated Regions, Adult, Aged, Aged, 80 and over, Alleles, Case-Control Studies, Exons, Female, Gene Expression, Gene Frequency, Genetic Association Studies, Genetic Predisposition to Disease, Haplotypes, Hepacivirus, Hepatitis C, HLA-G Antigens, Humans, Italy, Male, Middle Aged, Polymorphism, Single Nucleotide, Risk, Th1 Cells}, issn = {2059-2310}, doi = {10.1111/tan.12959}, author = {Catamo, E and Zupin, L and Freato, N and Polesello, V and Celsi, F and Croc{\`e}, S L and Masutti, F and Pozzato, G and Segat, L and Crovella, S} } @article {10532, title = {LTF and DEFB1 polymorphisms are associated with susceptibility toward chronic periodontitis development.}, journal = {Oral Dis}, volume = {23}, year = {2017}, month = {2017 Oct}, pages = {1001-1008}, abstract = {

OBJECTIVES: Chronic periodontitis is a common pathological condition that affects the supporting tissue of the teeth, leading to progressive alveolar bone destruction and teeth loss. The disease is caused by bacteria and derives from an altered host immune and inflammatory response, also involving different factors such as the oral hygiene, smoking, and genetic background. The innate immune response, the first line of host defense, could also play an important role in the susceptibility to chronic periodontitis. In this study, we evaluated the possible association between periodontal disease and seven genetic variations within DEFB1 and LTF genes, encoding for β-defensins 1 and lactoferrin (two members of oral innate immune system), in an Italian isolated population.

SUBJECTS AND METHODS: DEFB1 5{\textquoteright}UTR g. -52G>A (rs1799946), g. -44C>G (rs1800972), g. -20G>A (rs11362), 3{\textquoteright}UTR c*5G>A (rs1047031), c*87A>G (rs1800971), LTF p.Ala29Thr (rs1126477), and p.Lys47Arg (rs1126478) single nucleotide polymorphisms (SNPs) were analyzed in 155 healthy individuals and 439 chronic periodontitis patients from North-East Italy.

RESULTS: Significant associations were found between periodontitis and g. -20G>A (rs11362) and g. -44C>G (rs1800972) SNPs in DEFB1 gene as well as p.Ala29Thr (rs1126477) and p.Lys47Arg (rs1126478) SNPs in LTF gene.

DISCUSSION: Our results suggest the involvement of DEFB1 and LTF genetic variations in the susceptibility toward development of periodontitis.

}, keywords = {Adolescent, Adult, Aged, Aged, 80 and over, beta-Defensins, Case-Control Studies, Chronic Periodontitis, Female, Genetic Predisposition to Disease, Humans, Lactoferrin, Male, Middle Aged, Polymorphism, Single Nucleotide, Young Adult}, issn = {1601-0825}, doi = {10.1111/odi.12689}, author = {Zupin, L and Robino, A and Navarra, C O and Pirastu, N and Di Lenarda, R and Gasparini, P and Crovella, S and Bevilacqua, L} } @article {8353, title = {MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response.}, journal = {Scand J Immunol}, volume = {84}, year = {2016}, month = {2016 Jul}, pages = {61-9}, abstract = {

Hepatitis C is disease that damages the liver, and it is caused by the hepatitis C virus (HCV). The pathology became chronic in about 80\% of the cases due to virus persistence in the host organism. The standard of care consists of pegylated interferon plus ribavirin; however, the treatment response is very variable and different host/viral factors may concur in the disease outcome. The mannose-binding protein C (MBL) is a component of the innate immune system, able to recognize HCV and consecutively activating the immune response. MBL is encoded by MBL2 gene, and polymorphisms, two in the promoter region (H/L and X/Y) and three in exon 1 (at codon 52, 54 and 57), have been described as functionally influencing protein expression. In this work, 203 Italian HCV patients and 61 healthy controls were enrolled and genotyped for the five MBL2 polymorphisms mentioned above to investigate their role in HCV infection susceptibility, spontaneous viral clearance and treatment response. MBL2 polymorphisms were not associated with HCV infection susceptibility and with spontaneous viral clearance, while MBL2 O allele, O/O genotype, HYO haplotype and DP combined genotype (all correlated with low or deficient MBL expression) were associated with sustained virological response. Moreover, a meta-analysis to assess the role of MBL2 polymorphisms in HCV infection susceptibility was also performed: YA haplotype could be associated with protection towards HCV infection.

}, issn = {1365-3083}, doi = {10.1111/sji.12444}, author = {Zupin, L and Polesello, V and Alberi, G and Moratelli, G and Croc{\`e}, S L and Masutti, F and Pozzato, G and Crovella, S and Segat, L} } @article {3504, title = {HLA-G 14 bp deletion/insertion polymorphism and mother-to-child transmission of HIV.}, journal = {Tissue Antigens}, volume = {83}, year = {2014}, month = {2014 Mar}, pages = {161-7}, abstract = {

The human leukocyte antigen HLA-G, highly expressed at the maternal-fetal interface, has a pivotal role in mediating immune tolerance. In this study we investigated the influence of HLA-G 14 bp insertion polymorphism in human immunodeficiency virus (HIV)-1 mother-to-child HIV-1 transmission. The 14 bp insertion polymorphism was analyzed among 99 HIV-1 positive mothers and 329 infants born to HIV-positive mothers in Zambia, among whom vertical transmission status and timing had been determined. HLA-G 14 bp insertion polymorphism was detected using a custom TaqMan single nucleotide polymorphisms (SNPs) genotyping assay. Logistic regression was conducted to examine the associations between HLA-G alleles and the risk of HIV transmission. The 14 bp insertion allele was more frequent in HIV exposed-uninfected (EU) infants than in infected infants, and was associated with reduced risk of both in utero (IU) and intrapartum (IP) HIV transmission, after adjusting for maternal cluster of differentiation 4 (CD4) cell count and plasma viral load. Maternal HLA-G 14 bp insertion genotype and HLA-G concordance between mother and child were not associated with the risk of perinatal HIV transmission. The presence of the 14 bp insertion associates with protection toward IU and IP HIV infection in children from Zambia, suggesting that HLA-G could be involved in the vertical transmission of HIV.

}, keywords = {Adult, Alleles, Base Pairing, Child, Genotype, HIV Infections, HLA-G Antigens, Humans, INDEL Mutation, Infant, Infectious Disease Transmission, Vertical, Mothers, Polymorphism, Genetic, Young Adult}, issn = {1399-0039}, doi = {10.1111/tan.12296}, author = {Segat, L and Zupin, L and Kim, H-Y and Catamo, E and Thea, D M and Kankasa, C and Aldrovandi, G M and Kuhn, L and Crovella, S} }